IEX •
Healthcare •
Biotechnology •
Quote as of 08/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization5.46 mln
Float1.38 mln
Earnings Date11/12/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
-0.16
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
BioAtla is a San Diego-based biopharmaceutical company focused on developing antibody-based treatments for solid tumor cancers. Its pipeline includes several innovative drug candidates designed to target specific cancer types, including sarcoma, lung cancer, melanoma, and head and neck cancers, among others. Founded in 2007, the company's approach centers on antibodies that activate only under certain conditions found in tumors, aiming to improve treatment precision while reducing harm to healthy tissue.
